|
|
|
|
| | | | USD | EUR | GBP | JPY | 83.52 | 88.89 | 103.80 | 0.54 |
| | | | AED | AUD | CHF | CAD | 17.54 | 49.53 | 64.49 | 50.06 |
| | | | HKD | SAR | SGD | ZAR | 8.28 | 17.22 | 47.46 | 4.57 |
|
|
|
|
|
|
|
|
|
|
|
Industry :
|
Pesticides & Agrochemicals
|
|
|
|
|
|
|
|
|
|
52-Week-High (Rs.)
|
4032.00
|
|
|
52-Week-Low (Rs.)
|
3050.05
|
|
|
|
|
* BSE PRICES
|
|
|
|
|
Particulars | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Operational & Financial Ratios | | | | | | Earnings Per Share (Rs) | 79.70 | 53.93 | 46.74 | 32.05 | 29.54 | CEPS(Rs) | 94.28 | 66.98 | 58.06 | 41.70 | 36.25 | DPS(Rs) | 10.00 | 6.00 | 5.00 | 4.00 | 4.00 | Book NAV/Share(Rs) | 466.89 | 397.28 | 347.77 | 187.46 | 164.30 | Tax Rate(%) | 14.79 | 18.07 | 21.20 | 25.59 | 23.74 | Margin Ratios | | | | | | Core EBITDA Margin(%) | 23.44 | 21.05 | 21.59 | 20.12 | 18.77 | EBIT Margin(%) | 22.48 | 19.19 | 20.40 | 17.68 | 17.99 | Pre Tax Margin(%) | 21.90 | 18.90 | 19.65 | 17.11 | 17.72 | PAT Margin (%) | 18.66 | 15.48 | 15.49 | 12.73 | 13.51 | Cash Profit Margin (%) | 22.08 | 19.23 | 19.23 | 16.56 | 16.58 | Performance Ratios | | | | | | ROA(%) | 13.02 | 9.75 | 11.01 | 10.08 | 10.68 | ROE(%) | 18.44 | 14.48 | 18.05 | 18.22 | 19.56 | ROCE(%) | 21.77 | 17.04 | 21.46 | 22.62 | 25.12 | Asset Turnover(x) | 0.70 | 0.63 | 0.71 | 0.79 | 0.79 | Sales/Fixed Asset(x) | 1.93 | 1.78 | 1.90 | 1.94 | 2.25 | Working Capital/Sales(x) | 1.52 | 1.54 | 1.50 | 5.34 | 3.45 | Efficiency Ratios | | | | | | Fixed Capital/Sales(x) | 0.52 | 0.56 | 0.52 | 0.52 | 0.45 | Receivable days | 41.74 | 49.55 | 47.52 | 63.56 | 71.90 | Inventory Days | 75.25 | 80.76 | 68.85 | 65.95 | 59.75 | Payable days | 91.85 | 109.17 | 100.55 | 107.51 | 104.12 | Valuation Parameters | | | | | | PER(x) | 37.98 | 52.31 | 48.23 | 36.49 | 34.91 | PCE(x) | 32.11 | 42.12 | 38.83 | 28.04 | 28.45 | Price/Book(x) | 6.48 | 7.10 | 6.48 | 6.24 | 6.28 | Yield(%) | 0.33 | 0.21 | 0.22 | 0.34 | 0.39 | EV/Net Sales(x) | 7.00 | 8.24 | 7.61 | 5.00 | 5.00 | EV/Core EBITDA(x) | 26.10 | 34.44 | 29.94 | 22.13 | 22.35 | EV/EBIT(x) | 30.07 | 41.17 | 35.45 | 26.93 | 26.17 | EV/CE(x) | 4.48 | 4.74 | 4.15 | 3.36 | 3.68 | M Cap / Sales | 7.34 | 8.45 | 7.86 | 4.88 | 5.01 | Growth Ratio | | | | | | Net Sales Growth(%) | 23.51 | 16.41 | 31.88 | 16.40 | 24.76 | Core EBITDA Growth(%) | 38.43 | 9.60 | 48.19 | 17.70 | 14.64 | EBIT Growth(%) | 43.64 | 8.55 | 52.33 | 13.23 | 15.08 | PAT Growth(%) | 47.79 | 15.37 | 60.64 | 8.49 | 11.21 | EPS Growth(%) | 47.79 | 15.37 | 45.84 | 8.49 | 11.21 | Financial Stability Ratios | | | | | | Total Debt/Equity(x) | 0.00 | 0.04 | 0.06 | 0.20 | 0.02 | Current Ratio(x) | 3.27 | 2.78 | 2.74 | 1.35 | 1.57 | Quick Ratio(x) | 2.55 | 2.09 | 2.17 | 0.96 | 1.22 | Interest Cover(x) | 38.91 | 65.97 | 27.37 | 30.72 | 67.83 | Total Debt/Mcap(x) | 0.00 | 0.01 | 0.01 | 0.03 | 0.00 |
|
|
|
|
|
|